Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
May 15, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001569222-20-000001.pdf
0001569222-20-000001.rtf
0001569222-20-000001.xls
May 15, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001559515-20-000002.pdf
0001559515-20-000002.rtf
0001559515-20-000002.xls
May 15, 2020 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001140361-20-011794.pdf
0001140361-20-011794.rtf
0001140361-20-011794.xls
May 14, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-061771.pdf
0001104659-20-061771.rtf
0001104659-20-061771.xls
May 14, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-061768.pdf
0001104659-20-061768.rtf
0001104659-20-061768.xls
May 12, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-060294.pdf
0001104659-20-060294.rtf
0001104659-20-060294.xls
May 11, 2020 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-20-059097.pdf
0001104659-20-059097.rtf
0001104659-20-059097.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 11, 2020 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001558370-20-006235.pdf
0001558370-20-006235.rtf
0001558370-20-006235.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 29, 2020 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

View HTML
0001104659-20-053354.pdf
0001104659-20-053354.rtf
0001104659-20-053354.xls
Apr 29, 2020 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-20-053658.pdf
0001104659-20-053658.rtf
0001104659-20-053658.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2020 Intercept Pharmaceuticals, Inc.